P. de la Vega

发表

Discovery of Gene Function by Expression Profiling of the Malaria Parasite Life Cycle

Patricia De la Vega, S. Batalov, Yingyao Zhou, 2003, Science.

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

Patricia De la Vega, S. Hoffman, J. Sacci, 2002, The Journal of infectious diseases.

The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification.

Yingyao Zhou, Yingyao Zhou, E. Winzeler, 2005, Molecular and biochemical parasitology.

Molecular Mechanism of Host Specificity in Plasmodium falciparum Infection

T. McCutchan, J. Sacci, P. de la Vega, 2003, Journal of Biological Chemistry.

Induction in Humans of CD8+ and CD4+ T Cell and Antibody Responses by Sequential Immunization with Malaria DNA and Recombinant Protein1

S. Hoffman, D. Carucci, P. de la Vega, 2004, The Journal of Immunology.

Plasmodium vivax Promiscuous T-Helper Epitopes Defined and Evaluated as Linear Peptide Chimera Immunogens

M. Galinski, P. de la Vega, A. Moreno, 2002, Infection and Immunity.

Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.

S. Hoffman, P. de la Vega, E. Franke, 1996, Journal of immunology.

Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.

S. Hoffman, D. Freilich, J. Sacci, 2007, The Journal of infectious diseases.

Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium berghei

P. de la Vega, E. Bergmann-Leitner, C. Ockenhouse, 2010, PloS one.

Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity

S. Hoffman, D. Carucci, D. Freilich, 2016, Malaria Journal.

Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody.

S. Hoffman, P. de la Vega, M. Sedegah, 1995, Experimental parasitology.

Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: enhancement by exogenous tetrahydrobiopterin

S. Hoffman, P. de la Vega, A. Nussler, 1994, Infection and immunity.

TAP‐mediated processing of exoerythrocytic antigens is essential for protection induced with radiation‐attenuated Plasmodium sporozoites

P. de la Vega, N. Steers, A. Pichugin, 2016, European journal of immunology.

Quantification of sporozoite invasion, migration, and development by microscopy and flow cytometry.

M. Mota, P. de la Vega, P. Sinnis, 2013, Methods in molecular biology.

An Immunologically Cryptic Epitope of Plasmodium falciparum Circumsporozoite Protein Facilitates Liver Cell Recognition and Induces Protective Antibodies That Block Liver Cell Invasion*

T. McCutchan, P. de la Vega, Sanjai Kumar, 2005, Journal of Biological Chemistry.

HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim-sulfamethoxazole inhibit plasmodium liver stages.

M. Fay, P. de la Vega, W. Borkowsky, 2012, The Journal of infectious diseases.

Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes

Patricia De la Vega, S. Hoffman, S. Hoffman, 1997, Infection and immunity.

Distinct Malaria Parasite Sporozoites Reveal Transcriptional Changes That Cause Differential Tissue Infection Competence in the Mosquito Vector and Mammalian Host

Xinxia Peng, S. Kappe, P. de la Vega, 2008, Molecular and Cellular Biology.

Identification and Characterization of the Protective Hepatocyte Erythrocyte Protein 17 kDa Gene of Plasmodium yoelii, homolog of Plasmodium falciparum Exported Protein 1*

S. Hoffman, P. de la Vega, D. Doolan, 1996, The Journal of Biological Chemistry.

The effect of antiretrovirals on Plasmodium falciparum liver stages

P. de la Vega, W. Borkowsky, P. Sinnis, 2013, AIDS.

Transgenic Parasites Stably Expressing Full-Length Plasmodium falciparum Circumsporozoite Protein as a Model for Vaccine Down-Selection in Mice Using Sterile Protection as an Endpoint

Michael D. Porter, P. de la Vega, A. Crisanti, 2013, Clinical and Vaccine Immunology.

Multiple Antigen Peptide Vaccines against Plasmodium falciparum Malaria

Jay A. Berzofsky, J. Kathleen Moch, J. David Haynes, 2010, Infection and Immunity.

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA

S. Hoffman, D. Freilich, J. Aguiar, 2012, Human vaccines & immunotherapeutics.

Two-step chromatographic purification of recombinant Plasmodium falciparum circumsporozoite protein from Escherichia coli.

J. Sacci, P. de la Vega, D. Lanar, 2001, Journal of chromatography. B, Biomedical sciences and applications.

Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals

A. James, J. Sacci, P. de la Vega, 2009, Malaria Journal.

Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

A. Aly, S. Kappe, A. Cowman, 2009, Proceedings of the National Academy of Sciences.

Binding and Invasion of Liver Cells by Plasmodium falciparum Sporozoites

T. McCutchan, J. Sacci, P. de la Vega, 2002, The Journal of Biological Chemistry.

Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants.

S. Hoffman, R. Hunter, J. Sacci, 1998, Vaccine.

Early Transcriptional Responses of HepG2-A16 Liver Cells to Infection by Plasmodium falciparum Sporozoites*

P. de la Vega, S. Paik, Y. Murata, 2011, The Journal of Biological Chemistry.

In vitro production of infectious Plasmodium falciparum sporozoites

S. Hoffman, A. Aly, S. Kappe, 2022, Nature.

Disruption of the Plasmodium falciparum liver‐stage antigen‐1 locus causes a differentiation defect in late liver‐stage parasites

S. Kappe, A. Cowman, P. de la Vega, 2011, Cellular microbiology.

PfSPATR, a Plasmodium falciparum Protein Containing an Altered Thrombospondin Type I Repeat Domain Is Expressed at Several Stages of the Parasite Life Cycle and Is the Target of Inhibitory Antibodies*

S. Hoffman, D. Carucci, P. de la Vega, 2003, Journal of Biological Chemistry.

First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.

S. Kappe, A. Cowman, P. de la Vega, 2013, Vaccine.

Immunofluorescent and immunoelectron microscopic localization of protein antigens in red cells infected with the human malaria Plasmodium falciparum.

I. Sherman, P. de la Vega, J. Greenan, 1988, Annals of tropical medicine and parasitology.

Early Transcriptional Responses of HepG2-A16 Liver Cells to Infection by Plasmodium falciparum Sporozoites*

P. de la Vega, S. Paik, Y. Murata, 2011, The Journal of Biological Chemistry.

Multiple Antigen Peptide Vaccines against Plasmodium falciparum Malaria

J. Berzofsky, J. K. Moch, J. Haynes, 2010, Infection and Immunity.